Show simple item record

dc.contributor.authorYilman, M.
dc.contributor.authorErenler, A. K.
dc.contributor.authorBaydin, A.
dc.date.accessioned2020-06-21T13:45:45Z
dc.date.available2020-06-21T13:45:45Z
dc.date.issued2015
dc.identifier.issn1128-3602
dc.identifier.urihttps://hdl.handle.net/20.500.12712/14170
dc.descriptionBAYDIN, AHMET/0000-0003-4987-0878en_US
dc.descriptionWOS: 000361590800015en_US
dc.descriptionPubMed: 26367724en_US
dc.description.abstractCopeptin is important in determining the prognosis of the disease, assigning mortality, setting treatment modalities and increasing the patients' chances for survival in life threatening conditions. Any stress factor activating the hypothalamic-pituitary-adrenal (HPA) axis causes an increase in arginine vasopressin (AVP) plasma concentrations also known as antidiuretic hormone (ADH). Copeptin is derived from preprovasopressin along with neurophysin II and AVP. Copeptin is released in an equimolar ratio to AVP. Various studies have shown copeptin to be an independent indicator in determining the prognosis of the disease and assigning mortality. The purpose of this review was to analyze the advantages of copeptin in patients with life threatening illnesses by reviewing medical data bases.en_US
dc.language.isoengen_US
dc.publisherVerduci Publisheren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCopeptinen_US
dc.subjectCritical careen_US
dc.subjectEmergency Departmenten_US
dc.titleCopeptin: a diagnostic factor for critical patientsen_US
dc.typearticleen_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume19en_US
dc.identifier.issue16en_US
dc.identifier.startpage3030en_US
dc.identifier.endpage3036en_US
dc.relation.journalEuropean Review For Medical and Pharmacological Sciencesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record